(07-22-2018, 07:19 PM)mikesez Wrote:

(07-22-2018, 06:56 PM)jj82284 Wrote: There's only so much negotiating u can do when it takes 10 years to approve a drug.  That's bureaucratic cost in addition to the actual development of the drug.  Computer development doesn't have to deal with that kind of regulatory infrastructure.  That's a big reason why so much analytical talent heads to programming instead of organic chemistry.

---

They can only afford to go that low BECAUSE their model is based on recouping their r&d in the domestic market and essentially the other countries free ride for pennies over cost of production.  

Just focusing on reducing price and not th e actual COST to come to market will only lead to shortages and chasing away capital.

See above. 
Just look at how much they have been spending on stock buybacks.
The "US funds R&D for the world" thing might have been true at one time but it hasn't been true for a while.  We are just marks for big stock holders now.